Coherus BioSciences - Choice Without Compromise

Coherus

Committed to High Quality, Not High Cost.

Coherus is a leading global biosimilar company. We are committed to improving patient lives by expanding access to life-changing biologic medicines.

One Team. One Mission.

Dedicated to delivering high-quality products at a lower cost. Unlike other companies, we are primarily focused on biosimilar development.

Scientific Platform

Learn What Makes Coherus Unique

Latest News

Coherus BioSciences to Report Fourth Quarter and Full Year 2018 Financial Results on February 28th

Coherus BioSciences Announces New Employment Inducement Grants

Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgen’s Humira Biosimilar Formulation

At Coherus, we believe that biosimilars have the potential to help offset the increasing cost of healthcare.

Learn About The Power of Biosimilars